Need for clarification of results in the recent meta-analysis about SULT1A1 codon 213 polymorphism and breast cancer risk
Letter to the Editor
KeywordsBreast Cancer Breast Cancer Risk Methodological Issue Comparison Model Breast Cancer Case
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
The authors are fully responsible for all the content and editorial decisions and have not received any financial support or other form of remuneration related to the development of this article.
- 1.Sun Y, Zang Z, Xu X, Zhang Z, Zhong L, Zan W, Zhao Y, Sun L (2010) The association of SULT1A1 codon 213 polymorphism and breast cancer susceptibility: meta-analysis from 16 studies involving 23,445 subjects. Breast Cancer Res Treat. doi: 10.1007/s10549-010-0953-5
- 2.The MARIE-GENICA Consortium (2010) Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women. Breast Cancer Res Treat 119:463–474Google Scholar
- 5.Economopoulos KP, Sergentanis TN (2010) Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: convergence and divergence of the two recent meta-analyses. Breast Cancer Res Treat. doi: 10.1007/s10549-010-1143-1
© Springer Science+Business Media, LLC. 2010